Cargando…

Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis

The release of humoral factors between cancer cells and the microenvironmental cells is critical for metastasis; however, the roles of secreted miRNAs in non-cell autonomous cancer progression against microenvironmental cells remain largely unknown. Here, we demonstrate that the neutral sphyngomyeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosaka, Nobuyoshi, Iguchi, Haruhisa, Hagiwara, Keitaro, Yoshioka, Yusuke, Takeshita, Fumitaka, Ochiya, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2013
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624465/ https://www.ncbi.nlm.nih.gov/pubmed/23439645 http://dx.doi.org/10.1074/jbc.M112.446831

Ejemplares similares

nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe(−/−) Mice
por: Lallemand, Tom, et al.
Publicado: (2018)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation
por: Álvarez-Fernández, Hadrián, et al.
Publicado: (2022)

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
por: Tallon, Carolyn, et al.
Publicado: (2022)

Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia
por: Sackmann, Valerie, et al.
Publicado: (2019)

Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
por: Hagiwara, Keitaro, et al.
Publicado: (2012)

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
por: Huang, Meixiang, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
por: Tallon, Carolyn, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
por: Tallon, Carolyn, et al.
Publicado: (2023)

Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling
por: Yabu, T, et al.
Publicado: (2015)

The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures
por: Houston, D. A., et al.
Publicado: (2016)

The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice
por: Matsuzaka, Yasunari, et al.
Publicado: (2020)

Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
por: Gu, LiZe, et al.
Publicado: (2013)

Trash or Treasure: extracellular microRNAs and cell-to-cell communication
por: Kosaka, Nobuyoshi, et al.
Publicado: (2013)

Transcriptome analysis alk-SMase knockout mice reveals the effect of alkaline sphingomyelinase on liver
por: Zhu, Jiang, et al.
Publicado: (2022)

Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes
por: Katsuda, Takeshi, et al.
Publicado: (2013)

Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications
por: Hagiwara, Keitaro, et al.
Publicado: (2013)

Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro
por: Lang, Jennifer K., et al.
Publicado: (2016)

Sphingomyelinase D Activity in Sicarius tropicus Venom: Toxic Potential and Clues to the Evolution of SMases D in the Sicariidae Family
por: Lopes, Priscila Hess, et al.
Publicado: (2021)

The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
por: Fujita, Yu, et al.
Publicado: (2015)

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy
por: Tominaga, Naoomi, et al.
Publicado: (2014)

A robust screening method for dietary agents that activate tumour-suppressor microRNAs
por: Hagiwara, Keitaro, et al.
Publicado: (2015)

Vascular Smooth Muscle Cell Neutral Sphingomyelinase 2 in the Release of Exosomes and Vascular Calcification
por: Pavlic, Angelina, et al.
Publicado: (2022)

Neutral sphingomyelinase‐2 and cardiometabolic diseases
por: Sindhu, Sardar, et al.
Publicado: (2021)

Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

An Insight into the Roles of MicroRNAs and Exosomes in Sarcoma
por: Kohama, Isaku, et al.
Publicado: (2019)

Correction: Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

Neutral sphingomyelinase 2 controls exosome secretion by counteracting V-ATPase-mediated endosome acidification
por: Choezom, Dolma, et al.
Publicado: (2022)

An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells
por: Yamamoto, Yusuke, et al.
Publicado: (2011)

Inhibition of neutral sphingomyelinase 2 promotes remyelination
por: Yoo, Seung-Wan, et al.
Publicado: (2020)

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
por: Lea, Simon R, et al.
Publicado: (2016)

PAI‐1, a target gene of miR‐143, regulates invasion and metastasis by upregulating MMP‐13 expression of human osteosarcoma
por: Hirahata, Mio, et al.
Publicado: (2016)

The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment
por: Urabe, Fumihiko, et al.
Publicado: (2017)

Tick-Borne Flavivirus Inhibits Sphingomyelinase (IsSMase), a Venomous Spider Ortholog to Increase Sphingomyelin Lipid Levels for Its Survival in Ixodes scapularis Ticks
por: Regmi, Pravesh, et al.
Publicado: (2020)

Comparative marker analysis of extracellular vesicles in different human cancer types
por: Yoshioka, Yusuke, et al.
Publicado: (2013)

Neutral Sphingomyelinase and Breast Cancer Research
por: Hwang, Sun-Yong, et al.
Publicado: (2015)

Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons
por: Zhou, Wenshuo, et al.
Publicado: (2019)

Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma
por: Schumacher, Fabian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8rog9gvr7tndf95gdtof5aumq